SCHEMBL17547820

SCHEMBL17547820

CC(C)c1c(-c2cccc(CCN(C)C)c2)[nH]c2c(C#N)cnn2c1=O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 10/20 0.41
▸ USP1 O94782 2/20 0.38
▸ KDM5B Q9UGL1 5/20 0.37
▸ PIK3CD O00329 1/20 0.36
▸ PIK3R1 P27986 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ PIK3CB P42338 1/20 0.36
▸ KDM5C P41229 3/20 0.36
▸ KDM3A Q9Y4C1 1/20 0.36
▸ HTR7 P34969 4/20 0.35
▸ HTR1A P08908 2/20 0.35
▸ KDM6B O15054 1/20 0.35
▸ KDM5D Q9BY66 1/20 0.35
▸ KDM4C Q9H3R0 1/20 0.35
▸ PHF8 Q9UPP1 1/20 0.35
▸ KDM4D Q6B0I6 1/20 0.34
▸ KDM4A O75164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16092274 0.90 KDM5A (0.46) KDM5AKDM5BKDM5CKDM6BKDM5D
SCHEMBL16092258 0.88 KDM5B (0.46) KDM5AKDM5BKDM5CKDM6BKDM5D
SCHEMBL16092428 0.84 KDM5A (0.38) KDM5AKDM5BKDM5CKDM6BKDM5D
SCHEMBL17547850 0.83 AURKA (0.42) KDM5AKDM5BKDM5CKDM6BKDM5D
SCHEMBL17549545 0.83 SRC (0.40) KDM5B
SCHEMBL16092493 0.83 KDM5B (0.48) KDM5AKDM5BKDM5CKDM6BKDM5D
SCHEMBL16092293 0.83 KDM5A (0.39) KDM5AKDM5BKDM5CKDM6BKDM5D
SCHEMBL16092243 0.83 KDM5A (0.43) KDM5AKDM5BKDM5CKDM6BKDM5D
SCHEMBL17547860 0.82 FFAR1 (0.43) KDM5AKDM5BKDM5CKDM6BKDM5D
SCHEMBL16092255 0.82 KDM5B (0.42) KDM5AKDM5BKDM5CKDM6BKDM5D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B KDM5A 1/4885USP1 843/4885KDM5B 3/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B KDM5A 1/4885USP1 843/4885KDM5B 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback